Allele: A Division of Catalyst BC

Allele’s core mission is to combine market–proven cannabis genetics with modern agricultural science with the goal of developing commercial cannabis cultivars to maximize product quality and drive financial performance. Allele sources the highest quality genetic material then, integrates genomic mapping and predictive breeding platforms, and utilizes modern tissue culture procedures to provide turnkey genetics solutions that maximize profit and minimize risk for large-scale commercial cannabinoid production.

Genetics Improvement:

Allele will work alongside your cultivation team to identify specific genetic development needs in order to design and implement propagation and breeding programs that will produce unique and proprietary cultivars, providing maximized productivity and profitability. We have developed a dynamic and growing portfolio of unique, exotic and desirable cannabis genetics that exhibit elevated levels of resin content, terpenes, and cannabinoids (THC-A, CBD, CBG, and CBC). Our cultivars have years of proven commercial viability in multiple markets utilizing many types of cultivation methods.  We will work with you to determine your company’s specific genetic needs and implement breeding programs that produce unique and proprietary cultivars that allow you to maximize productivity and profit.  By using the latest genomic mapping, laboratory grade tissue culture and micropropagation techniques we are providing science backed cannabis genetics to a modern market.

Service offerings include:

Award Winning & Proven Cannabis Genetics
Unreleased, Non-Market Exposed Cannabis Genetics
Cannabis Genetics Development
Cannabis Genetics Preservation
Micropropagation (International only)
Targeted Pollination
Seed Production
Genetics Consulting
Genetics Selection
Production Planning

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

New York Cannabis Provisional License (2026): From Provisional to Operational
For operators whose strength is growing cannabis, Virginia’s emerging adult-use market presents a significant opportunity – and a cultivation license is the gateway to it. The June 2026 framework authorizes the Virginia Cannabis Control Authority (CCA) to begin accepting license applications on or after February 1, 2027 and issuing licenses on or after May 1, 2027. It also establishes five cultivation tiers with maximum canopies ranging from 5,000 to 35,000 square feet.
New York Cannabis Proximity Rules (2026): Site Selection After the Correction
In New York cannabis retail, location is not a late-stage detail – it is a threshold licensing issue. A proposed dispensary can satisfy ownership and financial requirements and still fail because the site conflicts with a school, a house of worship, another dispensary, a municipal opt-out, or local zoning. The risk became unmistakable in 2025, when OCM concluded that its long-standing school-distance review did not match the wording of then-existing Cannabis Law § 72.
New York Cannabis Cultivation License & Canopy Expansion (2026)
For cultivators, New York in 2026 presents an unusual and genuinely interesting situation. The general application window is closed, but in March 2026 the Cannabis Control Board adopted Resolution 2026-19 directing OCM to process canopy-expansion amendment requests from existing adult-use cultivator licensees. The action followed OCM’s projection that the market could face a 356,000-pound supply gap in the 2026 growing season.
New York Processor Type 3 Branding License (2026): The Open White-Label Path
New York currently accepts Processor Type 3 Branding license applications year-round. For the right business, it can be an efficient way to establish a compliant brand presence in New York’s fast-growing adult-use market because it permits white-label agreements without requiring the brand licensee to operate a cannabis manufacturing facility. It does not, however, authorize the brand licensee to possess cannabis, manufacture products, distribute inventory, or sell directly to consumers.
New York Cannabis Microbusiness License (2026): The Limited-Vertical Path
In a market that otherwise generally separates the supply and retail tiers, the New York cannabis microbusiness license is a limited exception – and that makes it one of the most interesting and most misunderstood licenses in the state. It allows one small-scale operator to cultivate cannabis and conduct at least one additional authorized activity: processing, distribution, or retail sale.
How to Open a Dispensary in New York (2026): The Real Path Right Now
New York’s last adult-use application window closed in December 2023, and the Office of Cannabis Management (OCM) is still working through the roughly 7,000 applications it received then. That does not mean the door is shut – but it does mean the honest path into New York retail today looks very different from “fill out an application and wait.”